Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Treatment false advertisement in China: a tragedy

On April 12, 2016, a 21-year-old man died in China, generating many reactions and questions. He had been diagnosed in 2014 with synovial sarcoma, a malignant tumour with no effective therapies.1,2 He searched for a treatment strategy on Baidu—the largest Chinese language search engine. An attractive therapeutic method based on bioimmunotherapy3 was displayed as the first search result, and brought hope for the patient and his family. After four treatment sessions, the family had spent most of their money, but the patient died.